• Covington & Burling LLP | News, Events & Publications | AIM High: Covington Advises US Biotech Northwest Biotherapeutics on ...
  Covington & Burling LLP announces its role in advising US biotechnology company Northwest Biotherapeutics, Inc. on its admission to AIM and £15 million placing, which valued the company at approximately £68 million on a fully-diluted basis. The transact
  in Public bookmarks with aim biotechnology biotherapy cancer covington northwestbiotherapeutics otc stock treatment by 4 users

covington from all users